KBG syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Ankrd11 is a chromatin regulator involved in autism that is essential for neural development.
|
25556659 |
2015 |
KBG syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
We present the largest cohort of KBG syndrome cases confirmed by ANKRD11 variants reported so far, consisting of 20 patients from 13 families.
|
25424714 |
2015 |
KBG syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Further delineation of the KBG syndrome phenotype caused by ANKRD11 aberrations.
|
25424714 |
2015 |
KBG syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
In addition, microdeletion of 16q24.3, including ANKRD11, has been reported to result in the KBG syndrome phenotype.
|
25464108 |
2015 |
KBG syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Electroencephalographic findings in KBG syndrome: a child with novel mutation in ANKRD11 gene.
|
25543316 |
2015 |
KBG syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Three de novo mutations were identified in ANKRD11 demonstrating a phenotypic overlap with KBG syndrome.
|
25125236 |
2014 |
KBG syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
This patient provided additional evidence on the influence of ANKRD11 in KBG syndrome and suggested that deletion limited to ANKRD11 is unlikely to cause autism.
|
25187894 |
2014 |
KBG syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
De novo ANKRD11 and KDM1A gene mutations in a male with features of KBG syndrome and Kabuki syndrome.
|
24838796 |
2014 |
KBG syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
This family provides additional evidence that ANKRD11 causes KBG syndrome, and the mild phenotype in the mosaic form suggests that KBG phenotypes might be dose dependent, differentiating it from the more variable 16q24.3 microdeletion syndrome.
|
23494856 |
2013 |
KBG syndrome
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Their features are compared with those of previously reported patients with KBG syndrome aiding in the delineation of neurocognitive phenotype associated to ANKRD11 mutations.
|
23184435 |
2013 |
KBG syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Here, we present a patient with clinically confirmed KBG syndrome carrying a de novo 690-kb deletion at 16q24.3 involving part of ANKRD11.
|
23463723 |
2013 |
KBG syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We report on a patient, who showed many manifestations of KBG syndrome and was found to harbor a de novo ANKRD11 mutation, c.362T > A (p.Met121Lys).
|
23369839 |
2013 |
KBG syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Their features are compared with those of previously reported patients with KBG syndrome aiding in the delineation of neurocognitive phenotype associated to ANKRD11 mutations.
|
23184435 |
2013 |
KBG syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
It remains unknown if deletion of the entire ANKRD11 causes KBG syndrome.
|
22307766 |
2012 |
KBG syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Our results demonstrate that mutations in ANKRD11 cause KBG syndrome and outline a fundamental role of ANKRD11 in craniofacial, dental, skeletal, and central nervous system development and function.
|
21782149 |
2011 |
KBG syndrome
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Our results demonstrate that mutations in ANKRD11 cause KBG syndrome and outline a fundamental role of ANKRD11 in craniofacial, dental, skeletal, and central nervous system development and function.
|
21782149 |
2011 |
KBG syndrome
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Our results demonstrate that mutations in ANKRD11 cause KBG syndrome and outline a fundamental role of ANKRD11 in craniofacial, dental, skeletal, and central nervous system development and function.
|
21782149 |
2011 |
KBG syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Our results demonstrate that mutations in ANKRD11 cause KBG syndrome and outline a fundamental role of ANKRD11 in craniofacial, dental, skeletal, and central nervous system development and function.
|
21782149 |
2011 |
KBG syndrome
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Our results demonstrate that mutations in ANKRD11 cause KBG syndrome and outline a fundamental role of ANKRD11 in craniofacial, dental, skeletal, and central nervous system development and function.
|
21782149 |
2011 |
KBG syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our results demonstrate that mutations in ANKRD11 cause KBG syndrome and outline a fundamental role of ANKRD11 in craniofacial, dental, skeletal, and central nervous system development and function.
|
21782149 |
2011 |
KBG syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
An ENU-induced mutation in the Ankrd11 gene results in an osteopenia-like phenotype in the mouse mutant Yoda.
|
17986521 |
2008 |
KBG syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
KBG syndrome
|
0.800 |
Biomarker
|
disease |
CTD_human |
|
|
|
Autism Spectrum Disorders
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Contiguous gene deletions involving ANKRD11 in 16q24.3 are associated with autism spectrum disorder (ASD) and intellectual disability (ID), while 16q24.1 deletions affecting FOXF1 are associated with congenital renal malformations, alveolar capillary dysplasia, and various other abnormalities.
|
23335808 |
2013 |
Autism Spectrum Disorders
|
0.330 |
Biomarker
|
disease |
BEFREE |
In addition, copy number variation in the 16q24.3 region that includes ANKRD11 results in a variable phenotype that overlaps with KBG syndrome and also includes autism spectrum disorders and other dysmorphic facial features.
|
23494856 |
2013 |